Patient Forum: Platform Trials: Accelerating Clinical Research in Scleroderma (2024)

In this session, you'll learn more about platform trials and their role in accelerating clinical research in scleroderma. After covering the basics, you'll learn about CONQUEST, a highly innovative platform clinical trial. CONQUEST is designed to rapidly advance promising treatments for scleroderma and to identify agents that should progress from phase 2b to phase 3 clinical trials.

Presented by Gregory Gordon, MD, JD (Chief Medical Officer, Scleroderma Research Foundation), Dinesh Khanna, MD, MS (Professor of Medicine, University of Michigan), and Tobey Maher, MD (Professor of Clinical Medicine, Keck School of Medicine of the University of Southern California).

This session was originally presented on June 3, 2024, as part of the 3rd annual SRF Patient Forum, “Collaborating for a Cure.”

Learn more at http://www.srfcure.org